24
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Chemical Studies on a Nepalese Panacea - Shilajit (I)

, , , , &
Pages 179-182 | Published online: 27 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Rahul Hasija, Sundeep Chaurasia & Swati Gupta. (2021) Formulation design, optimization and in vivo evaluation of oral co-encapsulated resveratrol-humic acid colloidal polymeric nanocarriers. Pharmaceutical Development and Technology 26:9, pages 953-966.
Read now

Articles from other publishers (7)

Amritpal Singh. 2017. Regulatory and Pharmacological Basis of Ayurvedic Formulations. Regulatory and Pharmacological Basis of Ayurvedic Formulations 251 256 .
Dinesh Kumar Surapaneni, Sree Rama Shiva Shanker Adapa, Kumari Preeti, Gangineni Ravi Teja, Muruganandam Veeraragavan & Sairam Krishnamurthy. (2012) Shilajit attenuates behavioral symptoms of chronic fatigue syndrome by modulating the hypothalamic–pituitary–adrenal axis and mitochondrial bioenergetics in rats. Journal of Ethnopharmacology 143:1, pages 91-99.
Crossref
Carlos Carrasco-Gallardo, Leonardo Guzmán & Ricardo B. Maccioni. (2012) Shilajit : A Natural Phytocomplex with Potential Procognitive Activity . International Journal of Alzheimer's Disease 2012, pages 1-4.
Crossref
Mohd. Aamir Mirza, Niyaz Ahmad, Suraj Prakash Agarwal, Danish Mahmood, M. Khalid Anwer & Z. Iqbal. (2011) Comparative evaluation of humic substances in oral drug delivery. Results in Pharma Sciences 1:1, pages 16-26.
Crossref
Suraj P. Agarwal, Rajesh Khanna, Ritesh Karmarkar, Md. Khalid Anwer & Roop K. Khar. (2007) Shilajit: a review. Phytotherapy Research 21:5, pages 401-405.
Crossref
Shibnath Ghosal, Sraboni Baumik & Sukumar Chattopadhyay. (2006) Shilajit induced morphometric and functional changes in mouse peritoneal macrophages. Phytotherapy Research 9:3, pages 194-198.
Crossref
Shibnath Ghosal, Jawahar Lal, Sushil K. Singh, Raj K. Goel, Arun K. Jaiswal & Salil K. Bhattacharya. (2006) The need for formulation of Shilajit by its isolated active constituents. Phytotherapy Research 5:5, pages 211-216.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.